ESMO 2010 - Dr. Jordan Berlin, MD from Vanderbilt A phase 2, randomized, double-blind, placebo-controlled study of hedgehog pathway inhibitor (HPI) GDC-0449 in patients with previously untreated metastatic colorectal cancer (mCRC) - 100200

Spotlight
Video

ESMO 2010 - Dr. Jordan Berlin, MD from Vanderbilt A phase 2, randomized, double-blind, placebo-controlled study of hedgehog pathway inhibitor (HPI) GDC-0449 in patients with previously untreated metastatic colorectal cancer (mCRC)

Loading........
Description: ESMO 2010 - Dr. Jordan Berlin, MD from Vanderbilt A phase 2, randomized, double-blind, placebo-controlled study of hedgehog pathway inhibitor (HPI) GDC-0449 in patients with previously untreated metastatic colorectal cancer (mCRC)
Shared By : europe_meeting_2010
Posted on : 10/10/10
Added : 7 years ago
Category : Colorectal Cancer



More From europe_meeting_2010

Nothing found.